VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,452,184 | -91.3% | 151,276 | -91.1% | 0.01% | -92.7% |
Q1 2023 | $28,260,911 | +131.4% | 1,697,352 | +30.7% | 0.19% | +236.8% |
Q4 2022 | $12,210,600 | +245.6% | 1,299,000 | 0.0% | 0.06% | +171.4% |
Q3 2022 | $3,533,000 | -7.7% | 1,299,000 | -1.9% | 0.02% | -64.4% |
Q2 2022 | $3,826,000 | +1655.0% | 1,323,809 | +2548.4% | 0.06% | +2850.0% |
Q1 2018 | $218,000 | – | 49,986 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |